Latest Insider Transactions at Opgen Inc (OPGN)
This section provides a real-time view of insider transactions for Opgen Inc (OPGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of OPGEN INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of OPGEN INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 29
2024
|
Aei Capital LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
514,138
+6.3%
|
$514,136,971,724
$999998.0 P/Share
|
|
Aug 27
2024
|
Aei Capital LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
564,971
+7.34%
|
$564,970,435,029
$999999.0 P/Share
|
|
Aug 16
2024
|
Aei Capital LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,600,000
+35.41%
|
$9,808,164,000,000
$2724490.0 P/Share
|
|
Aug 13
2024
|
Aei Capital LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
566,494
+16.03%
|
$242,869,573,656
$428724.0 P/Share
|
|
Aug 08
2024
|
Aei Capital LTD > 10% Shareholder |
BUY
Open market or private sale
|
Direct |
600,000
+20.0%
|
$272,449,200,000
$454082.0 P/Share
|
|
Aug 05
2024
|
Aei Capital LTD > 10% Shareholder |
BUY
Open market or private sale
|
Direct |
1,800,000
+50.0%
|
$1,643,877,000,000
$913265.0 P/Share
|
|
Apr 11
2024
|
Avraham Ben Tzvi Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Apr 11
2024
|
David Natan Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Apr 11
2024
|
David E. Lazar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Apr 11
2024
|
Matthew Charles Mc Murdo Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Jun 07
2023
|
Yvonne Schlaeppi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+33.33%
|
-
|
|
Jun 07
2023
|
Mario Crovetto Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+33.33%
|
-
|
|
Jun 07
2023
|
R Don Elsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+32.79%
|
-
|
|
Jun 07
2023
|
Prabhavathi Fernandes Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+33.33%
|
-
|
|
Jun 07
2023
|
William E. Rhodes Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,500
+33.33%
|
-
|
|
Mar 31
2023
|
Oliver Schacht Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,469
+38.74%
|
-
|
|
Mar 31
2023
|
Johannes Bacher Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,434
+33.65%
|
-
|
|
Mar 03
2023
|
Oliver Schacht Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,938
+21.09%
|
-
|
|
Mar 03
2023
|
Johannes Bacher Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,063
+14.54%
|
-
|
|
Mar 02
2023
|
Oliver Schacht Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+26.09%
|
-
|
|
Mar 02
2023
|
Johannes Bacher Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,125
+17.82%
|
-
|
|
Nov 08
2022
|
Yvonne Schlaeppi Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+50.0%
|
-
|
|
Jun 09
2022
|
Mario Crovetto Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+33.33%
|
-
|
|
Jun 09
2022
|
R Don Elsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+32.26%
|
-
|
|
Jun 09
2022
|
Prabhavathi Fernandes Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+33.33%
|
-
|
|
Jun 09
2022
|
William E. Rhodes Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+33.33%
|
-
|
|
Mar 03
2022
|
Oliver Schacht Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,750
+36.05%
|
-
|
|
Mar 03
2022
|
Johannes Bacher Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,250
+20.73%
|
-
|
|
Jan 26
2022
|
Johannes Bacher Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+29.41%
|
$0
$0.85 P/Share
|
|
Nov 19
2021
|
Johannes Bacher Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+22.22%
|
$10,000
$1.53 P/Share
|
|
Nov 18
2021
|
Oliver Schacht Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+25.0%
|
$10,000
$1.5 P/Share
|
|
Sep 15
2021
|
Johannes Bacher Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+16.67%
|
$15,000
$3.07 P/Share
|
|
Sep 15
2021
|
Oliver Schacht Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+20.0%
|
$15,000
$3.08 P/Share
|
|
Jun 10
2021
|
Johannes Bacher Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+29.12%
|
$40,000
$2.28 P/Share
|
|
Jun 10
2021
|
Oliver Schacht Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
5,000
+50.0%
|
$10,000
$2.24 P/Share
|
|
Jun 10
2021
|
Oliver Schacht Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+26.69%
|
$30,000
$2.24 P/Share
|
|
Jun 09
2021
|
Mario Crovetto Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Jun 09
2021
|
R Don Elsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+25.0%
|
-
|
|
Jun 09
2021
|
Prabhavathi Fernandes Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Jun 09
2021
|
William E. Rhodes Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
May 17
2021
|
Timothy C Dec Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
583
+27.87%
|
-
|
|
May 17
2021
|
Evan/ Fa Jones Director |
BUY
Exercise of conversion of derivative security
|
Direct |
883
+3.76%
|
-
|
|
Oct 27
2020
|
Evan/ Fa Jones Director |
SELL
Open market or private sale
|
Indirect |
1,748
-7.44%
|
$3,496
$2.35 P/Share
|
|
Jun 27
2016
|
Merck & Co., Inc. > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
2,734,427
+33.56%
|
-
|
|
May 19
2016
|
Merck & Co., Inc. > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
1,200,000
+30.94%
|
-
|